Same preservative used in H1N1 Shots Puts Children at Risk for Brainstem Injury
A new study in the leading scientific journal NeuroToxicology lends further credence to parents and scientists concerned about an increasingly aggressive childhood vaccine schedule and toxic vaccine components. A team led by researchers at the University of Pittsburgh found that infant macaque monkeys receiving a single Hepatitis B vaccine containing the mercury-based preservative thimerosal underwent significant delays in developing critical reflexes controlled by the brainstem. The infant macaques that did not receive vaccines developed normally.
Government vaccine guidelines were expanded in 1991 to include a Hepatitis B vaccine for infants within the first few days of life, even though the disease is primarily transmitted sexually or spread through the use of dirty needles. The introduction of the shot was part of a greatly accelerated vaccine schedule that coincides with the drastic increase in autism, which now affects one in 100 American children. Thimerosal was removed from U.S. Hepatitis B vaccines in 2000 but was not recalled from the market and was administered for approximately two more years. It still remains in other vaccines including all multi-dose shots for both the seasonal flu and H1N1.
Current government recommendations for seasonal flu and H1N1 call for pregnant women to receive both vaccines, and children as young as six months to receive as many as four separate flu shots. "This also doesn't take into account that nursing infants may be exposed to additional mercury through breastmilk should both mother and baby be vaccinated," says National Autism Association (NAA) board chair Lori McIlwain. "This study's outcome confirms that such an over-the-top toxic vaccine schedule is an assault on the developing brains of our children."
Specifically, the study found: